Enhancing glutamatergic neurotransmission by positive allosteric modulators (PAM) of AMPA receptors has emerged as an alternative approach for treating narcolepsy. Chinese researchers described the development and optimization of a series of diphenylmethyl-sulfinyl-bridged bisamide derivatives as AMPA receptor PAMs with wakefulness-promoting potential.